Tabrizi Z, Ahmed N, Horder J, Storr S, Benest A
Front Physiol. 2021; 12:672987.
PMID: 34795596
PMC: 8593113.
DOI: 10.3389/fphys.2021.672987.
Moustou A, Alexandrou P, Stratigos A, Giannopoulou I, Vergou T, Katsambas A
An Bras Dermatol. 2014; 89(6):891-7.
PMID: 25387493
PMC: 4230657.
DOI: 10.1590/abd1806-4841.20143210.
Veale D
Arthritis Res Ther. 2014; 15(6):224.
PMID: 24611179
PMC: 4061722.
DOI: 10.1186/ar4414.
Quarta L, Corrado A, DOnofrio F, Maruotti N, Cantatore F
Rheumatol Int. 2009; 30(10):1367-70.
PMID: 19609527
DOI: 10.1007/s00296-009-1060-y.
Elias P, Arbiser J, Brown B, Rossiter H, Man M, Cerimele F
Am J Pathol. 2008; 173(3):689-99.
PMID: 18688025
PMC: 2527083.
DOI: 10.2353/ajpath.2008.080088.
VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis.
Benest A, Harper S, Herttuala S, Alitalo K, Bates D
Cardiovasc Res. 2007; 78(2):315-23.
PMID: 18065770
PMC: 2613351.
DOI: 10.1093/cvr/cvm094.
Increased lymphangiogenesis in joints of mice with inflammatory arthritis.
Zhang Q, Lu Y, Proulx S, Guo R, Yao Z, Schwarz E
Arthritis Res Ther. 2007; 9(6):R118.
PMID: 17997858
PMC: 2246237.
DOI: 10.1186/ar2326.
Angiogenesis in psoriasis and psoriatic arthritis: clues to disease pathogenesis.
Leong T, Fearon U, Veale D
Curr Rheumatol Rep. 2005; 7(4):325-9.
PMID: 16045837
DOI: 10.1007/s11926-005-0044-5.
[The lymphatic system and the skin. Classification, clinical aspects und histology].
Marsch W
Hautarzt. 2005; 56(3):277-93.
PMID: 15731928
DOI: 10.1007/s00105-005-0912-y.
Immunopathology of psoriasis and psoriatic arthritis.
Veale D, Ritchlin C, FitzGerald O
Ann Rheum Dis. 2005; 64 Suppl 2:ii26-9.
PMID: 15708930
PMC: 1766860.
DOI: 10.1136/ard.2004.031740.
Pathways of cell activation in spondyloarthropathies.
Fearon U, Veale D
Curr Rheumatol Rep. 2001; 3(5):435-42.
PMID: 11564376
DOI: 10.1007/s11926-996-0015-5.
Immunohistochemical markers for arthritis in psoriasis.
Veale D, Barnes L, Rogers S, FitzGerald O
Ann Rheum Dis. 1994; 53(7):450-4.
PMID: 7944617
PMC: 1005369.
DOI: 10.1136/ard.53.7.450.
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
Dvorak H, Brown L, Detmar M, Dvorak A
Am J Pathol. 1995; 146(5):1029-39.
PMID: 7538264
PMC: 1869291.
Involved and uninvolved skin from psoriatic subjects: are they equally diseased? Assessment by skin transplanted to congenitally athymic (nude) mice.
Krueger G, CHAMBERS D, Shelby J
J Clin Invest. 1981; 68(6):1548-57.
PMID: 7033288
PMC: 370959.
DOI: 10.1172/jci110409.
Circulating immune complexes, serum immunoglobulins, and acute phase proteins in psoriasis and psoriatic arthritis.
Laurent M, Panayi G, Shepherd P
Ann Rheum Dis. 1981; 40(1):66-9.
PMID: 6970552
PMC: 1000659.
DOI: 10.1136/ard.40.1.66.
Mast cells in the initial stages of psoriasis.
TORUNIOWA B, Jablonska S
Arch Dermatol Res. 1988; 280(4):189-93.
PMID: 3233011
DOI: 10.1007/BF00513956.
Carbonic anhydrase--a marker for fenestrated capillaries in psoriasis.
Jungkunz W, Eichhorn M, Worl J, Marsch W, Holzmann H
Arch Dermatol Res. 1992; 284(3):146-9.
PMID: 1503498
DOI: 10.1007/BF00372707.
Psoriasis: current concepts in management.
Hodge L, Comaish J
Drugs. 1977; 13(4):288-96.
PMID: 324749
DOI: 10.2165/00003495-197713040-00004.
Electron microscopical study of psoriasis pustulosa.
Braun-Falco O, Maciejewski W
Arch Dermatol Res (1975). 1977; 260(3):167-78.
PMID: 74981
DOI: 10.1007/BF00561411.
